NO982902D0 - FremgangsmÕte og preparatsett for Õ hindre befruktning hos hunn-pattedyr som omfatter en kombinasjon av gestagen og °strogen - Google Patents
FremgangsmÕte og preparatsett for Õ hindre befruktning hos hunn-pattedyr som omfatter en kombinasjon av gestagen og °strogenInfo
- Publication number
- NO982902D0 NO982902D0 NO982902A NO982902A NO982902D0 NO 982902 D0 NO982902 D0 NO 982902D0 NO 982902 A NO982902 A NO 982902A NO 982902 A NO982902 A NO 982902A NO 982902 D0 NO982902 D0 NO 982902D0
- Authority
- NO
- Norway
- Prior art keywords
- gestagen
- combination
- strogen
- mammals including
- preparation kit
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19549264A DE19549264A1 (de) | 1995-12-23 | 1995-12-23 | Verfahren und Kit zur Kontrazeption |
| PCT/DE1996/002486 WO1997023228A2 (de) | 1995-12-23 | 1996-12-20 | Verfahren und kit zur kontrazeption bei weiblichen säugern, bestehend aus einer kombination von gestagen und estrogen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO982902L NO982902L (no) | 1998-06-22 |
| NO982902D0 true NO982902D0 (no) | 1998-06-22 |
Family
ID=7781724
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO982902A NO982902D0 (no) | 1995-12-23 | 1998-06-22 | FremgangsmÕte og preparatsett for Õ hindre befruktning hos hunn-pattedyr som omfatter en kombinasjon av gestagen og °strogen |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6995149B1 (pl) |
| EP (1) | EP0868188B1 (pl) |
| JP (1) | JP2000502108A (pl) |
| KR (1) | KR19990076685A (pl) |
| AT (1) | ATE244567T1 (pl) |
| AU (1) | AU716249B2 (pl) |
| BR (1) | BR9612207A (pl) |
| CA (1) | CA2241192A1 (pl) |
| CZ (1) | CZ291743B6 (pl) |
| DE (2) | DE19549264A1 (pl) |
| DK (1) | DK0868188T3 (pl) |
| ES (1) | ES2202498T3 (pl) |
| HU (1) | HUP9901662A3 (pl) |
| IL (1) | IL124472A (pl) |
| IS (1) | IS4753A (pl) |
| MX (1) | MX9804395A (pl) |
| NO (1) | NO982902D0 (pl) |
| NZ (1) | NZ330741A (pl) |
| PL (1) | PL187180B1 (pl) |
| PT (1) | PT868188E (pl) |
| SK (1) | SK79298A3 (pl) |
| UA (1) | UA59356C2 (pl) |
| WO (1) | WO1997023228A2 (pl) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2754179B1 (fr) | 1996-10-08 | 1998-12-24 | Theramex | Nouvelle composition hormononale et son utilisation |
| WO2001030355A1 (fr) | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation |
| CA2301162A1 (en) * | 1997-09-12 | 1999-03-25 | Michael Jay Gast | Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin |
| EP1535618A1 (en) * | 2003-11-26 | 2005-06-01 | Schering Aktiengesellschaft | Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions |
| DE102008036825A1 (de) * | 2008-08-05 | 2010-02-11 | Aicuris Gmbh & Co. Kg | Schwangerschaftsvermeidung durch Gestagene |
| WO2010042607A1 (en) * | 2008-10-08 | 2010-04-15 | Agile Therapeutics, Inc | Transdermal delivery |
| ES2795455T3 (es) | 2008-10-08 | 2020-11-23 | Agile Therapeutics Inc | Suministro transdérmico |
| WO2010042610A1 (en) * | 2008-10-08 | 2010-04-15 | Agile Therapeutics, Inc. | Transdermal delivery |
| EP2410859A4 (en) | 2009-03-27 | 2013-03-13 | Agile Therapeutics Inc | TRANSDERMAL ADMINISTRATION |
| JP5954736B2 (ja) * | 2011-01-12 | 2016-07-20 | 国立大学法人 宮崎大学 | 難治性炎症性腸疾患の予防又は治療方法 |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| HUE055562T2 (hu) | 2011-11-23 | 2021-11-29 | Therapeuticsmd Inc | Természetes kombinációjú hormon helyettesítõ kiszerelések, és terápiák ezekkel |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| RU2016143081A (ru) | 2014-05-22 | 2018-06-26 | Терапьютиксмд, Инк. | Натуральные комбинированные гормонозаместительные составы и терапии |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
| KR20180126582A (ko) | 2016-04-01 | 2018-11-27 | 쎄러퓨틱스엠디, 인코퍼레이티드 | 스테로이드 호르몬 약제학적 조성물 |
| US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0368373A1 (en) * | 1988-10-13 | 1990-05-16 | Akzo Nobel N.V. | Multi-phase contraceptive preparation |
| NL9301562A (nl) * | 1993-09-09 | 1995-04-03 | Saturnus Ag | Preparaat voor substitutietherapie. |
| HU228434B1 (en) * | 1995-06-07 | 2013-03-28 | Ortho Mcneil Pharm Inc | Transdermal medicament for administering 17-deacetyl norgestimate alone or in combination with an estrogen |
| US5770226A (en) * | 1996-07-10 | 1998-06-23 | Wake Forest University | Combined pharmaceutical estrogen-androgen-progestin oral contraceptive |
| US6139873A (en) * | 1996-07-10 | 2000-10-31 | Cedars-Sinai Medical Center | Combined pharmaceutical estrogen-androgen-progestin |
| US6479475B1 (en) * | 1996-07-26 | 2002-11-12 | Wyeth | Oral contraceptive |
| US5888543A (en) * | 1996-07-26 | 1999-03-30 | American Home Products Corporation | Oral contraceptives |
| FR2754179B1 (fr) * | 1996-10-08 | 1998-12-24 | Theramex | Nouvelle composition hormononale et son utilisation |
| US5898032A (en) * | 1997-06-23 | 1999-04-27 | Medical College Of Hampton Roads | Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy |
| AU758144B2 (en) * | 1998-08-17 | 2003-03-13 | State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon, The | Gene regulating circadian clock function and photoperiodism |
-
1995
- 1995-12-23 DE DE19549264A patent/DE19549264A1/de not_active Withdrawn
-
1996
- 1996-12-20 SK SK792-98A patent/SK79298A3/sk unknown
- 1996-12-20 CZ CZ19982000A patent/CZ291743B6/cs not_active IP Right Cessation
- 1996-12-20 WO PCT/DE1996/002486 patent/WO1997023228A2/de not_active Application Discontinuation
- 1996-12-20 UA UA98074032A patent/UA59356C2/uk unknown
- 1996-12-20 KR KR1019980704797A patent/KR19990076685A/ko not_active Application Discontinuation
- 1996-12-20 BR BR9612207A patent/BR9612207A/pt not_active Application Discontinuation
- 1996-12-20 PT PT96946221T patent/PT868188E/pt unknown
- 1996-12-20 ES ES96946221T patent/ES2202498T3/es not_active Expired - Lifetime
- 1996-12-20 EP EP96946221A patent/EP0868188B1/de not_active Expired - Lifetime
- 1996-12-20 CA CA002241192A patent/CA2241192A1/en not_active Abandoned
- 1996-12-20 PL PL96327182A patent/PL187180B1/pl not_active IP Right Cessation
- 1996-12-20 AT AT96946221T patent/ATE244567T1/de not_active IP Right Cessation
- 1996-12-20 NZ NZ330741A patent/NZ330741A/xx unknown
- 1996-12-20 JP JP9523223A patent/JP2000502108A/ja active Pending
- 1996-12-20 HU HU9901662A patent/HUP9901662A3/hu unknown
- 1996-12-20 IL IL12447296A patent/IL124472A/en not_active IP Right Cessation
- 1996-12-20 DK DK96946221T patent/DK0868188T3/da active
- 1996-12-20 DE DE59610600T patent/DE59610600D1/de not_active Expired - Lifetime
- 1996-12-20 AU AU19219/97A patent/AU716249B2/en not_active Ceased
- 1996-12-20 US US09/091,665 patent/US6995149B1/en not_active Expired - Fee Related
-
1998
- 1998-05-22 IS IS4753A patent/IS4753A/is unknown
- 1998-06-03 MX MX9804395A patent/MX9804395A/es not_active IP Right Cessation
- 1998-06-22 NO NO982902A patent/NO982902D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO982902L (no) | 1998-06-22 |
| KR19990076685A (ko) | 1999-10-15 |
| ATE244567T1 (de) | 2003-07-15 |
| EP0868188A2 (de) | 1998-10-07 |
| PL327182A1 (en) | 1998-11-23 |
| PL187180B1 (pl) | 2004-05-31 |
| CZ9802000A3 (cs) | 1998-11-11 |
| SK79298A3 (en) | 2000-06-12 |
| WO1997023228A2 (de) | 1997-07-03 |
| DE19549264A1 (de) | 1997-06-26 |
| IS4753A (is) | 1998-05-22 |
| ES2202498T3 (es) | 2004-04-01 |
| AU716249B2 (en) | 2000-02-24 |
| MX9804395A (es) | 1998-09-30 |
| EP0868188B1 (de) | 2003-07-09 |
| JP2000502108A (ja) | 2000-02-22 |
| IL124472A (en) | 2001-07-24 |
| DK0868188T3 (da) | 2003-10-06 |
| BR9612207A (pt) | 1999-07-13 |
| CZ291743B6 (cs) | 2003-05-14 |
| IL124472A0 (en) | 1998-12-06 |
| PT868188E (pt) | 2003-11-28 |
| US6995149B1 (en) | 2006-02-07 |
| AU1921997A (en) | 1997-07-17 |
| NZ330741A (en) | 2000-03-27 |
| HUP9901662A2 (hu) | 1999-09-28 |
| DE59610600D1 (de) | 2003-08-14 |
| HUP9901662A3 (en) | 1999-11-29 |
| UA59356C2 (uk) | 2003-09-15 |
| CA2241192A1 (en) | 1997-07-03 |
| WO1997023228A3 (de) | 1997-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO982902L (no) | FremgangsmÕte og preparatsett for Õ hindre befruktning hos hunn-pattedyr som omfatter en kombinasjon av gestagen og °strogen | |
| TR199802705T2 (xx) | Progestojen-anti-progestojen k�r� | |
| NO976067L (no) | Farmasöytisk kombinasjonspreparat, sett og fremgangsmåte for hormonell prevensjon | |
| ES2174920T3 (es) | Producto de combinacion para la contracepcion que contiene agentes antagonistas de progesterona y un agente gestageno. | |
| IS4146A (is) | Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara | |
| PL327146A1 (en) | Antagonists of the gonadotrophin liberating hormone | |
| MX9804850A (es) | Antagonistas de hormona liberadora de gonadotropina. | |
| PL319373A1 (en) | Method of producing single doses by wet granulation | |
| ATE91410T1 (de) | Osmotische dosierungsform. | |
| BG101427A (en) | Competitive progesterone antagonists for regulating female fertility as required | |
| UA33487A (uk) | Спосіб лікування підгострих запалювальних захворювань придатків матки | |
| GR900100369A (en) | Contraception compositions and methods | |
| MX9804819A (es) | Antagonistas de hormona liberadora de gonadotropina. |